Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcrc.2020.11.012 http://scihub22266oqcxt.onion/10.1016/j.jcrc.2020.11.012 33260010!7680030!33260010     free     free     free       J+Crit+Care 2021 ; 62 (?): 46-48 Nephropedia Template TP {{tp|p=33260010|t=2021. COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study |pdf=|usr=}}{{33260010}} gab.com Text COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study JO: J Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=33260010 #FOAvip Patients with COVID-19 ARDS have distinct physiological and immunological phenotypes compared to patients with non-COVID ARDS. Patients with COVID-19 ARDS (n = 32) had a significant improvement in PaO(2): FiO(2) ratio (p = 0.046) following low-dose steroid treatment, unlike patients with non-COVID ARDS (n = 16) (p = 0.529). Patients with COVID-19 ARDS had a greater fall in CRP compared to patients with non-COVID ARDS, albeit not statistically significant (p = 0.07). Our novel findings highlight differences in the underlying physiological and immunological phenotypes between COVID-19 and non-COVID ARDS, with implications for future ARDS studies. Twit Text FOAVip COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study ????J Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=33260010 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33260010 #FOAvip English Wikipedia <ref>{{Cite pmid|33260010}}</ref> COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study #MMPMID33260010 Longobardo A; Snow TAC; Montanari C; Shulman R; Singer M; Arulkumaran N J Crit Care 2021[Apr]; 62 (?): 46-48 PMID33260010show ga Patients with COVID-19 ARDS have distinct physiological and immunological phenotypes compared to patients with non-COVID ARDS. Patients with COVID-19 ARDS (n = 32) had a significant improvement in PaO(2): FiO(2) ratio (p = 0.046) following low-dose steroid treatment, unlike patients with non-COVID ARDS (n = 16) (p = 0.529). Patients with COVID-19 ARDS had a greater fall in CRP compared to patients with non-COVID ARDS, albeit not statistically significant (p = 0.07). Our novel findings highlight differences in the underlying physiological and immunological phenotypes between COVID-19 and non-COVID ARDS, with implications for future ARDS studies. |*COVID-19 Drug Treatment[MESH] |Adult[MESH] |Aged[MESH] |Anti-Inflammatory Agents/*therapeutic use[MESH] |C-Reactive Protein/drug effects[MESH] |COVID-19/*physiopathology[MESH] |Female[MESH] |Humans[MESH] |Hydrocortisone/therapeutic use[MESH] |London/epidemiology[MESH] |Male[MESH] |Methylprednisolone/therapeutic use[MESH] |Middle Aged[MESH] |Phenotype[MESH] |Respiratory Distress Syndrome/*drug therapy/*physiopathology[MESH] |Respiratory Mechanics[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH]COVID-19 and non-COVID ARDS patients demonstrate a distinct response t(epmc).pdf DeepDyve Pubget Overpricing